Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Antigen therapy in chronic brucellosis].

J Roux

    Developments in Biological Standardization
    |January 1, 1976
    PubMed
    Summary

    Repeated injections of a heat-killed Brucella melitensis vaccine stabilize chronic brucellosis in 75% of patients. This treatment involves multiple series of subcutaneous injections, showing reduced hypersensitivity reactions after the second series.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Novel Long-Acting Ghrelin Analogue PEP-064 Restores Energy Balance in C26 and Lewis Lung Carcinoma-Induced cachexia in Mice.

    Journal of cachexia, sarcopenia and muscle·2026
    Same author

    Neurological manifestations in children with SARS-CoV-2 infection: a French multicentric cohort.

    European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society·2025
    Same author

    Species diversity in <i>Pseudocercospora</i>.

    Fungal systematics and evolution·2024
    Same author

    Fungal Planet description sheets: 1383-1435.

    Persoonia·2024
    Same author

    New and Interesting Fungi. 5.

    Fungal systematics and evolution·2023
    Same author

    Fungal Planet description sheets: 1182-1283.

    Persoonia·2022

    Area of Science:

    • Immunology
    • Infectious Diseases
    • Vaccinology

    Context:

    • Chronic brucellosis presents a persistent challenge in clinical management.
    • Existing treatments often yield suboptimal outcomes for long-term patient well-being.
    • Brucella melitensis is a primary causative agent of brucellosis globally.

    Purpose:

    • To evaluate the efficacy of a heat-killed Brucella melitensis vaccine in stabilizing chronic brucellosis.
    • To establish an optimal vaccination protocol for chronic brucellosis patients.
    • To assess treatment response through hypersensitivity testing.

    Summary:

    • A vaccine composed of heat-killed Brucella melitensis suspensions demonstrated significant improvement in 75% of chronic brucellosis cases.
    • The recommended protocol involves a series of 8 subcutaneous injections, administered twice weekly with increasing doses.
    • An average of 3 to 4 series, with 2-month intervals, is necessary for optimal results, with decreased hypersensitivity observed after the second series.

    Impact:

    • Provides a stabilized treatment option for chronic brucellosis, improving patient outcomes.
    • Suggests a potential reduction in immune over-reactivity associated with chronic infection.
    • Highlights the vaccine's effectiveness in cases presenting with asthenia and subjective syndromes.

    Related Experiment Videos